Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

1.4K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.4K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

793
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
793
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Information and Communication Technology Interventions to Enhance Mental Health Literacy Among Young Adults and Adolescents: A Meta-Analysis.

International journal of nursing practice·2026
Same author

Brain structural abnormalities in treatment-resistant schizophrenia.

Molecular psychiatry·2026
Same author

Pharmacoepidemiologic Trends and Factors Associated With Use and Dosing of Newer Antidepressants in 8357 Patients Across Asia: A Two-Decade Perspective.

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists·2026
Same author

An ENIGMA Consortium study of the relationship between white matter microstructure and positive and negative symptom severity in patients with schizophrenia.

Schizophrenia (Heidelberg, Germany)·2026
Same author

Psychotropic medications and their interactions with subcortical brain volume in bipolar disorder: An ENIGMA mega-analysis.

Molecular psychiatry·2026
Same author

Structural brain abnormalities and aggression in schizophrenia: mega-analysis of data from 2095 patients and 2861 healthy controls via the ENIGMA consortium.

Molecular psychiatry·2025

Related Experiment Video

Updated: Apr 28, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.7K

Accuracy of Machine Learning Models in Predicting Clinical Outcomes in Bipolar Disorder: A Systematic Review.

Jing Ling Tay1,2, Ling Zhang3, Kang Sim1,4,5

  • 1West Region, Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, Singapore 539747, Singapore.

Brain Sciences
|April 27, 2026
PubMed
Summary

Artificial intelligence shows promise in predicting bipolar disorder (BD) outcomes like relapse and functional status. Machine learning models, particularly tree-based algorithms, can forecast clinical progress using diverse patient data.

Keywords:
artificial intelligencebipolarhospitalisationrelapseremissiontreatment resistance

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.8K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Related Experiment Videos

Last Updated: Apr 28, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.8K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Area of Science:

  • Psychiatry and Mental Health
  • Artificial Intelligence in Medicine
  • Systematic Review Methodology

Background:

  • Bipolar disorder (BD) is a leading cause of global disability, marked by significant functional impairments.
  • The complex and heterogeneous nature of BD makes predicting clinical progress and outcomes challenging.
  • Artificial intelligence (AI) methods offer potential for enhancing predictive accuracy in BD management.

Purpose of the Study:

  • To systematically review the literature on the predictive accuracy of AI methods in forecasting clinical functioning, affective state, and relapse in patients with BD.
  • To identify key predictors utilized by AI models for BD outcomes.
  • To assess the performance of different AI approaches in BD prediction.

Main Methods:

  • Systematic literature search across six electronic databases until July 2025, adhering to PRISMA and Cochrane guidelines.
  • Inclusion of 40 articles reporting on AI applications for BD outcome prediction.
  • Data summarization and analysis of predictive accuracy metrics, including Area Under the Curve (AUC).

Main Results:

  • AI models demonstrated variable predictive accuracy for clinical functioning (AUC 0.59-0.72), affective state (AUC 0.57-0.97), and relapse (AUC 0.45-0.98).
  • Supervised, tree-based algorithms generally exhibited superior performance.
  • Effective predictive factors encompassed sociodemographic, clinical, psychological variables, wearable data, and speech/video recordings.

Conclusions:

  • Machine learning methods show potential for predicting clinical progress and outcomes in BD, including functional status, affective state, and relapse.
  • Further longitudinal studies are needed to validate predictive factors for early risk identification and improved BD management.